AbbVie Inc - Change In Other Working Capital
AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Change-In-Other-Working-Capital" stands at 0.142 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.135 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.135 Billion United States Dollars.
The 3 year change is 1.28 Billion United States Dollars.
The 5 year change is 0.192 Billion United States Dollars.
The 10 year change is 0.067 Billion United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2021, to it's latest available value, on 06/30/2024, is +1.41 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2024, to it's latest available value, on 06/30/2024, is -0.452 Billion.
Change In Other Working Capital for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Change In Other Working Capital | 905,699,262,464.00 |
 | Johnson & Johnson - Change In Other Working Capital | 486,508,953,600.00 |
 | Roche Holding AG - Change In Other Working Capital | 317,433,206,677.55 |
 | AstraZeneca PLC - Change In Other Working Capital | 280,205,508,085.11 |
 | Novartis AG - Change In Other Working Capital | 255,096,620,580.91 |